Scribe Therapeutics, Inc.
SCTX
13 insider filings · Latest: Jul 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Jul 29 11:09 PM | AH Bio Fund II, L.P.10% Owner | Purchase | 333,333 | $15.00 | $5.0M | 2,385,075(I) | View → |
| Jul 27, 2026 | Jul 29 10:50 PM | Carl L GordonDirector | Purchase | 1,000,000 | $15.00 | $15.0M | 1,348,825(I) | View → |
| Jul 27, 2026 | Jul 29 10:47 PM | ORBIMED ADVISORS LLCDirector | Purchase | 1,000,000 | $15.00 | $15.0M | 1,348,825(I) | View → |
| Jul 28, 2026 | Jul 29 1:30 AM | Behzad AghazadehDirector, 10% Owner, Other | Purchase | 7,905 | $18.25 | $144.3K | 3,088,888(I) | View → |
| Jul 24, 2026 | Jul 29 1:30 AM | Behzad AghazadehDirector, 10% Owner, Other | Purchase | 2,383,333 | $15.15 | $36.1M | 3,080,983(I) | View → |
| Jul 23, 2026 | Jul 28 1:42 AM | Svetlana LucasChief Business Officer | Purchase | 3,000 | $15.00 | $45.0K | 3,000(I) | View → |
| Jul 23, 2026 | Jul 28 1:20 AM | David ParrotChief Financial Officer | Purchase | 2,666 | $15.00 | $40.0K | 1,333(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Jul 29 11:09 PM | AH Bio Fund II, L.P.10% Owner | Conversion | 16,281,347 | — | 0(I) | View → |
| Jul 27, 2026 | Jul 29 10:50 PM | Carl L GordonDirector | Conversion | 2,065,672 | — | 0(I) | View → |
| Jul 27, 2026 | Jul 29 10:47 PM | ORBIMED ADVISORS LLCDirector | Conversion | 2,065,672 | — | 0(I) | View → |
| Jul 27, 2026 | Jul 29 8:21 PM | Jennifer A Doudna10% Owner | Conversion | 74,088 | — | 0(D) | View → |
| Jul 23, 2026 | Jul 28 8:46 PM | Brett Staahl10% Owner | Grant/Award | 38,770 | $15.00 | 19,385(D) | View → |
| Mar 13, 2026 | Jul 28 8:46 PM | Brett Staahl10% Owner | Grant/Award | 4,755 | $19.13 | 4,755(D) | View → |
| Jul 23, 2026 | Jul 28 1:42 AM | Svetlana LucasChief Business Officer | Grant/Award | 218,852 | $15.00 | 109,426(D) | View → |
| Mar 13, 2026 | Jul 28 1:42 AM | Svetlana LucasChief Business Officer | Grant/Award | 9,547 | $19.13 | 9,547(D) | View → |
| Jul 23, 2026 | Jul 28 1:26 AM | Benjamin L. OakesDirector, President, CEO, Other | Grant/Award | 694,383 | $15.00 | 429,599(D) | View → |
| Mar 13, 2026 | Jul 28 1:26 AM | Benjamin L. OakesDirector, President, CEO, Other | Grant/Award | 12,969 | $19.13 | 12,969(D) | View → |
| Jul 23, 2026 | Jul 28 1:25 AM | Carl L GordonDirector | Grant/Award | 14,725 | $15.00 | 14,725(D) | View → |
| Jul 23, 2026 | Jul 28 1:23 AM | James Dean WatsonDirector | Grant/Award | 14,725 | $15.00 | 14,725(D) | View → |
| Jul 23, 2026 | Jul 28 1:22 AM | Joshua BleharskiDirector | Grant/Award | 14,725 | $15.00 | 14,725(D) | View → |
| Jul 23, 2026 | Jul 28 1:20 AM | David ParrotChief Financial Officer | Grant/Award | 218,852 | $15.00 | 109,426(D) | View → |
| Mar 13, 2026 | Jul 28 1:20 AM | David ParrotChief Financial Officer | Grant/Award | 8,909 | $19.13 | 8,909(D) | View → |
| Jul 23, 2026 | Jul 28 1:04 AM | Behzad AghazadehDirector, Other | Grant/Award | 14,725 | $15.00 | 14,725(D) | View → |